Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

14 Mar 2018 07:00

RNS Number : 6253H
Alumasc Group PLC
14 March 2018
 

IMMEDIATE RELEASE 14 March 2018

 

The Alumasc Group plc (ALU.L) ("Alumasc" or the "group")

 

Trading Statement

 

Alumasc has so far experienced a slower than expected third quarter performance, both in terms of revenue and order intake. The principal reasons are macro-economic and industry specific:

· continuing delays in building contractor customers committing to new work following recent margin pressures, exacerbated in January by the insolvency of Carillion and the consequential impact across the industry;

· broader economic and political uncertainties impacting demand particularly in the commercial new build sector, with recent reports of construction output in this sector showing decline;

· delays to public housing refurbishment contracts in Scotland; and

· severe winter weather over the last few weeks.

These issues have had an impact particularly on Levolux's UK Solar Shading business, the Roofing & Walling division and the Gatic business within the Water Management division. It is likely that the first three of these factors will also impact the group's final quarter performance.

In contrast, areas where Alumasc's products and systems are sold via building distribution channels continue to perform well, with revenue growth remaining ahead of UK construction market growth at Alumasc Water Management Solutions, Rainclear and Timloc.

In view of all the above, the Board's latest forecasts are that group revenues for the year ending 30 June 2018 will be 4-5% below previous expectations, with a consequential reduction in previously expected underlying profit before tax of around 15%.

The integration of Wade, the specialist drainage business acquired by Alumasc on 1 February 2018, is progressing well and the Board believes that potential synergies as part of Alumasc's broader Water Management division and its "rain to drain" strategy are significant.

Whilst Alumasc is not immune to current market headwinds, there have been numerous positive strategic developments across the group over the last year that make Alumasc well positioned to continue its recent underlying growth trajectory over the medium to longer term. The level of specifications and the value of pre-order pipelines remain strong across the group, particularly Levolux's relatively new business streams of North American Solar Shading & Screening and UK Balconies & Balustrading where market share is growing rapidly from a low base. 

The Board continues to have confidence in the future growth prospects of the group in view of:

· The strategic positioning of our businesses in specialist growth markets;

· The consistent investment in recent years in growth resources and additional capacity, including the successful commissioning of the new Timloc factory in January;

· Levolux and Alumasc Water Management's potential to further develop export markets; and

· The recent acquisition of Wade, a high-quality business with development and synergy potential.

 

Enquiries:

The Alumasc Group plc

Paul Hooper (Chief Executive) 01536 383821

Andrew Magson (Finance Director) 01536 383844

 

Glenmill Partners Limited

Simon Bloomfield 07771 758514

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFTVRIVLIT
Date   Source Headline
4th May 20163:31 pmRNSHolding(s) in Company
21st Mar 20162:35 pmRNSDirector/PDMR Shareholding
9th Mar 20169:38 amRNSHolding(s) in Company
7th Mar 20164:22 pmRNSDirector/PDMR Shareholding
2nd Feb 20167:00 amRNSHalf Yearly Report
8th Jan 20167:00 amRNSNotice of Results
10th Dec 20153:53 pmRNSDirector/PDMR Shareholding
11th Nov 20153:16 pmRNSHolding(s) in Company
23rd Oct 20153:07 pmRNSResult of AGM
22nd Oct 20157:00 amRNSAGM Statement
15th Oct 20157:00 amRNSLevolux wins £3m order in the USA
23rd Sep 20154:50 pmRNSHolding(s) in Company
22nd Sep 20151:45 pmRNSHolding(s) in Company
9th Sep 20152:04 pmRNSHolding(s) in Company
8th Sep 20154:22 pmRNSHolding(s) in Company
7th Sep 20153:50 pmRNSHolding(s) in Company
3rd Sep 20157:00 amRNSAnnual Financial Report
1st Sep 20154:08 pmRNSHolding(s) in Company
13th Jul 20157:00 amRNSNotice of Results
6th Jul 20154:20 pmRNSHolding(s) in Company
26th Jun 20155:34 pmRNSDisposal of APC & Trading Update
2nd Apr 20152:03 pmRNSDirector/PDMR Shareholding
13th Mar 20152:10 pmRNSDirector/PDMR Shareholding
10th Mar 20159:42 amRNSDirector/PDMR Shareholding
2nd Mar 201512:48 pmRNSTR-1: Notification of Major Interest in Shares
13th Feb 20153:25 pmRNSDirector/PDMR Shareholding
3rd Feb 20157:00 amRNSHalf Yearly Report
14th Jan 20157:00 amRNSNotice of Results
21st Nov 20142:06 pmRNSTR1 Notification
30th Oct 20144:30 pmRNSResult of AGM
30th Oct 20147:00 amRNSInterim Management Statement
13th Oct 20141:46 pmRNSDirector/PDMR Shareholding
1st Oct 20148:00 amRNSDisposal
3rd Sep 20144:13 pmRNSHolding(s) in Company
2nd Sep 20147:01 amRNSFinal Results
2nd Sep 20147:00 amRNSDirectorate Change
8th Aug 20147:00 amRNSNotice of Results
24th Jun 20144:29 pmRNSDirector/PDMR Shareholding
16th May 20147:00 amRNSInterim Management Statement
11th Apr 20147:00 amRNSMajor Order
12th Mar 20144:19 pmRNSDirector/PDMR Shareholding
4th Feb 20147:00 amRNSInterim Results
8th Jan 20148:56 amRNSInterim Date Notification
24th Oct 20134:17 pmRNSResult of AGM
24th Oct 20137:00 amRNSInterim Management Statement
14th Oct 20133:21 pmRNSDirector/PDMR Shareholding
3rd Sep 20137:00 amRNSANNUAL RESULTS ANNOUNCEMENT
12th Jul 20137:00 amRNSTrading Statement
15th May 20137:00 amRNSInterim Management Statement
19th Mar 20134:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.